In agreement with our study, some groups have reported that ALKBH5 could serve as a novel prognostic biomarker that predicts a poor prognosis in colorectal (30) and pancreatic cancers (31). This evidence concerns the gene ALKBH5 and familial pancreatic carcinoma.